Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

InSite Vision and Nitten sign international licensing and distribution agreement for AzaSite

April 6, 2009

SARcode reports phase I results for its ocular therapeutic, SAR-1118

April 1, 2009

Clinical studies reveal efficacy of bepotastine in treating allergic conjunctivitis

March 31, 2009

Lux Biosciences reports results from Luveniq phase III LUMINATE trials in uveitis

March 30, 2009

Neurotech reports phase II NT-501 results in dry AMD

March 27, 2009

Allergan reports novel pyrrole compounds for the treatment of glaucoma

March 24, 2009

Sirion's sNDA for Durezol for uveitis is accepted for review by the FDA

March 23, 2009

Lux completes enrollment into second phase III LUCIDA clinical trial of Lumitect

March 20, 2009

Hydrogen sulphide-releasing latanoprost derivative shows potential for the treatment of glaucoma

March 19, 2009

Alimera reports 12-month interim safety and efficacy results for Iluvien

March 16, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...